Inhibitory effects of propolis granular A P C on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. 2003

Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Okayama University, 1-1-1 Tsushima-naka, Okayama 700-8530, Japan.

We examined the effect of propolis granular A. P. C on lung tumorigenesis in female A/J mice. Lung tumors were induced by the tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) administered in drinking water for 7 weeks in mice maintained on an AIN-76A semi-synthetic diet. Propolis granular A. P. C (100 mg/kg body wt.) was administered orally daily for 6 days/week from 1 week before NNK administration and throughout the experiment. Sixteen weeks after the NNK treatment, the mice were killed and the number of surface lung tumors was measured. The number of lung tumors in mice treated with NNK alone for 7 weeks (9.4 mg/mouse) was significantly more than in that observed in control mice. Propolis granular A. P. C significantly decreased the number of lung tumors induced by NNK. These results indicate that propolis granular A. P. C is effective in suppressing NNK-induced lung tumorigenesis in mice.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D011429 Propolis A resinous substance obtained from beehives that is used traditionally as an antimicrobial. It is a heterogeneous mixture of many substances. Bee Bread,Bee Glue,Bread, Bee,Glue, Bee
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D005260 Female Females
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
September 2009, Lung cancer (Amsterdam, Netherlands),
Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
January 2002, Cancer letters,
Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
December 1997, Carcinogenesis,
Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
February 2007, Cancer letters,
Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
November 2008, Cancer prevention research (Philadelphia, Pa.),
Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
September 2004, Cancer letters,
Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
September 1997, Carcinogenesis,
Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
June 1990, Carcinogenesis,
Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
February 2009, Oncology reports,
Yukio Sugimoto, and Yoshinori Iba, and Ryoji Kayasuga, and Yasushi Kirino, and Miyuki Nishiga, and Maria Alejandra Hossen, and Kiyoshi Okihara, and Hiroyuki Sugimoto, and Hideo Yamada, and Chiaki Kamei
September 1996, Carcinogenesis,
Copied contents to your clipboard!